Oncolytics Biotech (ONCY) PT Lowered to $5 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts ONCY Hot Sheet
Price: $0.83 +3.75%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 6
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 6
Join SI Premium – FREE
Canaccord Genuity analyst John Newman lowered the price target on Oncolytics Biotech (NASDAQ: ONCY) to $5.00 (from $6.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Smith & Nephew PLC. (SN:LN) (SNN) PT Lowered to GBP12.50 at Berenberg
- Grenke AG (GLJ:GR) (GKSGF) PT Lowered to EUR23 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
